Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Open Access Highly Access

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients

Andrea Sassen, Justine Rochon, Peter Wild, Arndt Hartmann, Ferdinand Hofstaedter, Stephan Schwarz† and Gero Brockhoff*†

Breast Cancer Research 2008, 10:R2 doi:10.1186/bcr1843

Accesses  

  • Last 30 days: 177 accesses
  • Last year: 2022 accesses
  • All time: 11115 accesses

Cited by

BioMed Central: 3 citations

Research   Open Access

Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma

Mikiko Takikita, Ran Xie, Joon-Yong Chung, Hanbyoul Cho, Kris Ylaya, Seung-Mo Hong, Christopher A Moskaluk, Stephen M Hewitt Journal of Translational Medicine 2011, 9:126 (29 July 2011)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Presence of HER4 associates with increased sensitivity to Herceptin™ in patients with metastatic breast cancer

Andrea Sassen, Simone Diermeier-Daucher, Manuela Sieben, Olaf Ortmann, Ferdinand Hofstaedter, Stephan Schwarz, Gero Brockhoff Breast Cancer Research 2009, 11:R50 (22 July 2009)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors

Thomas Frogne, Anne-Vibeke Laenkholm, Maria B Lyng, Katrine Henriksen, Anne E Lykkesfeldt Breast Cancer Research 2009, 11:R11 (24 February 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations